Mangoceuticals (MGRX) Cash from Operations (2023 - 2026)

Mangoceuticals (MGRX) has 4 years of Cash from Operations data on file, last reported at 1311343.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 42.35% year-over-year to 1311343.0; the trailing twelve-month figure through Mar 2026 stood at 4886817.0 (up 20.51% YoY), and the FY2025 full-year result was 5850255.0, down 20.28% from the prior year.
• Cash from Operations slipped to 1311343.0 in Q1 2026, from 1077761.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 991131.0 in Q1 2024 to a low of 2274781.0 in Q1 2025.
• A 4-year average of 1463288.38 and a median of 1311343.0 in 2026 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations jumped 45.19% in 2024 and tumbled 129.51% in 2025, its largest moves.
• Tracing MGRX's Cash from Operations over 4 years: stood at 1697741.0 in 2023, then jumped by 33.47% to 1129575.0 in 2024, then grew by 4.59% to 1077761.0 in 2025, then fell by 21.67% to 1311343.0 in 2026.
• Business Quant data shows MGRX's Cash from Operations at 1311343.0 in Q1 2026, 1077761.0 in Q4 2025, and 1241264.0 in Q3 2025.